chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reports site of injection felt warm to the touch starting approximately 12-24 hours after receiving the vaccine. Today is third day after receiving vaccine, patient reports site of injection feels itchy and red with some swelling (approximately 1.5 inch diameter). Patient does not report pain.
vaccine was administered. it was not realized until after administration that vaccine expired on 10/13/2021 (2 days prior)
Arm pain and swelling; Arm pain and swelling; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 18Mar2021 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. It was reported that the patient had no allergies to medications, food, or other products. Concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 18Mar2021, the patient experienced arm pain and swelling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment received for the adverse events was reported as no. The clinical outcome of the events arm pain and swelling was recovered on an unknown date in Mar2021.   Information about lot/batch number cannot be obtained. No further information is expected.
Employee received Flucelvax, single dose, (Seqirus, Lot #276539) via employee flu clinic on Wed. 9/30 at approx. 8 am. States she's receives flu vaccine every year  and denies any issues/reactions with vaccines in years past. At about 8-9 pm that same evening, developed sudden onset of hives on bilateral thighs and bilateral arms with mild pruritus. Denies prior history of allergies, allergic reactions or hives.  Next morning on 10/1, reports hives were more defined with increased pruritus. Took one dose Zyrtec and hives resolved. On night of 10/1, urticaria had sudden reappearance on face, neck, abdomen, back, arms, and legs. Reports increased pruritus. States she went to bed without sleep disturbances. Hives remained today and repeated dose of Zyrtec. Denies allergies to medications, food, animals or environmental. Denies new soap, detergent, lotion, environmental changes, or new foods.
Initial unsolicited report received from a nurse practitioner on 08-Jun-2015. This case is linked to cases: 2015SA081386, 2015SA081404 (same vaccine, same lot number). A 49 years old female patient, had received a dose of ADACEL (Batch number C4712AA, expiry date, route and site of administration was not reported) on 27-May-2015. The pre-existing physician diagnosed allergies, birth defects, medical conditions and illness at the time of vaccination was not reported. The concomitant medications were not provided. On 01-Jun-2015, 5 days post-vaccination, the patient experienced mild injection site reaction (no other symptoms) which was diagnosed with cellulitis. She was treated with MOTRIN. Laboratory investigations were not reported. The patient required ER/doctor visit. The patient had recovered on an unspecified date. Upon medical review, the case was considered as serious due to important medical event. List of documents held by sender: none.
This spontaneous report as received from a nurse practitioner professional refers to a 4 years old pediatric patient. On 18-MAY-2012, the patient was vaccinated with dose 1 GARDASIL instead of Polio vaccine due to a human error. It was unknown if the patient had sought medical attention. No adverse effect reported. Additional information has been requested.
Acute renal failure (ARF) (CMS/HCC) Septic shock (CMS/HCC)
my migraines have returned almost daily; lost 20 pounds; couldn't eat; throwing up a lot; pressure; headache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 78 year-old female patient received bnt162b2 (COMIRNATY), administered in arm right, administration date 12Oct2021 (Lot number: FF2589) at the age of 78 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Comirnaty (Dose:1, Lot: EN5318, Anatomical Location: Right arm), administration date: 05Feb2021, when the patient was 77 years old, for Covid-19 immunization; Comirnaty (Dose:2, Lot: EN6199, Anatomical Location: Right arm), administration date: 05Mar2021, when the patient was 77 years old, for Covid-19 immunization. The following information was reported: MIGRAINE (non-serious), outcome "recovering", described as "my migraines have returned almost daily"; WEIGHT DECREASED (non-serious), outcome "unknown", described as "lost 20 pounds"; EATING DISORDER (non-serious), outcome "unknown", described as "couldn't eat"; VOMITING (non-serious), outcome "unknown", described as "throwing up a lot"; HEAD DISCOMFORT (non-serious), outcome "unknown", described as "pressure"; HEADACHE (non-serious), outcome "unknown", described as "headache". The event "my migraines have returned almost daily" was evaluated at the physician office visit. Therapeutic measures were taken as a result of migraine.  Additional Information: Migraines that have returned almost daily: The caller was having almost no migraines for a long period of time and then after the caller received the booster dose Comirnaty, the migraines were daily. The caller has lost 20 pounds because couldn't eat and was throwing up a lot. Caller clarifies losing 20 pounds because couldn't eat and throwing up a lot occurred after receiving booster dose Comirnaty. Right now, at this moment the migraines seem a little better. The caller still has pressure and headache. Her doctor gave her a short term Prednisone and it did help while on, but now they are starting to come back again. Since it is heritary, she worries about her grandkids taking the vaccine.  Follow-up attempts are completed. No further information is expected.
No adverse effect by patient. Noted 1/15/2019 that KINRIX vaccine was given to 6 month old infant on 1/8/2019 when it is apparently only recommended for 4-6 year old.
Pt mentioned she had warm facial cheeks and red rash on facial cheeks - both facial cheeks - warm to touch. Received vaccine on 06-15-09.
This spontaneous report was received from a health care worker via field representative refers to a male patient of unspecified age (reported as under the age of 15). The patient's pertinent medical history and drug allergies were unspecified. On an unknown date the patient was vaccinated with first dose of GARDASIL 9 (Lot number and expiry date not provided) intramuscularly. Concomitant medications were not reported. On an unknown date, the patient experienced convulsions, syncope and lost of bladder control. The patient sought medical attention, reported as visited office and the treatment received was unspecified. The outcome of convulsions, syncope and lost of bladder control was unknown. The relatedness of convulsions, syncope and lost of bladder control with GARDASIL 9 was not reported. Upon internal review the event convulsions was determined to be medically significant. Additional information has been requested.
Local reaction on right thigh where PROQUAD was given. No evidence of infection. 3 in. in diameter. Red, swollen, hot to touch.
This spontaneous report as received from a Registered Nurse refers to a patient of unknown age and gender. On 09-AUG-2012 the patient was vaccinated with the first dose of GARDASIL (route, lot number and expiration date not reported). There was no concomitant medication reported. Nurse reported that on 01-AUG-2013 the patient was vaccinated with the second dose of GARDASIL (route, lot number and expiration date not reported) and on 29-OCT-2013 the patient was vaccinated with the third dose of GARDASIL (route, lot number and expiration date not reported). No adverse effects reported. Additional information has been requested.
Information has been received from a consumer referring to a male patient of unknown age who was one of his friend's sons. The patient had 5 siblings. The patient was one of the first 4 boy patients out of 6 children. The patient's pertinent medical history and drug reactions/allergies were not reported. On an unspecified date the patient was vaccinated with MMR II (dose, frequency, route and lot# were not reported). The reporter reported that on unspecified date, following MMR II vaccinations, the patient had some minor changes in his behaviors (type of behavior changes unspecified) and within a week of vaccinations with MMR II, his behavior changes were very clear and drastic and they all became less interactive and lethargic. On an unknown date the patient was diagnosed with autism. The reporter stated that his friend decided not to vaccinate his two other children with MMR II after experienced with his 4 boys and these two children did not have autism. The outcome of autism was not reported. This case was linked with other 3 cases as they are siblings. And the cases were from the same reporter. Additional information has been requested.
Developed shingles on Left trunk of body.  Case was mild no medical attention sought, however the rash lasted several weeks.  Developed red blisters filled with clear fluid, which crusted over & then healed.  Felt pain several days before rash was visible.  NO lasting effects.  I believe it could be related to the covid vaccination because I also got a papular rash on both hands after the first dose.
Epileptic patient presents in a catatonic state and movement difficulties. DX 145 R16 BP97/67 P66 Sat99. He was attended by medical personnel; staff who evaluated the patient, placed a normal rhythm heart monitor. The patient refuses to go to the hospital.
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On 23-JUL-2015 the patient was vaccinated with a dose of VARIVAX (Merck) (lot # K018959, expiration date 15-OCT-2016, dose and frequency were not reported), which was improperly stored(Incorrect product storage). No adverse symptoms were reported. This is one of several cases received from the same source. Additional information has been requested.
High eosinophils resulting in asthma, sinusitis requiring surgery and chronic heartburn
Shooting pain in left arm, nausea, chills, fever, sweating, then chilling, ice cold feet, weakness, red rash on 4th day. left arm still hurts day 6, still feel weak, chilling gone. Pain still in stomach, back and head.
Pt had erythematous blanching rash 5 hrs post vaccine - resolved on own/ with Benadryl.
The patient came in today (6/28/21) and got his second vaccine with his wife. I explained the recommended wait time and they chose to walk around the store instead. They returned to the window maybe 15 minutes later and he said that he had mild SOB only when he took in deep breaths. I went through the anaphylaxis related questions to make sure that he wasn't having any throat or tongue swelling and no trouble breathing and he said no to all questions and that "its really not even that bad, only if I breathe in deep. I just wasn't sure if it was a normal reaction." I explained to him that it wasn't normal and that if it continued and especially if it got worse he would want to go to one of the clinics/hospitals to get it checked out. Him and his wife didn't seem too worried but verbalized their understanding and continued to walk around/leave the store. Pt was not short of breath on presentation to pharmacy window. I called the patient about 20-30 minutes later to ask how he was doing and he stated that he "was feeling better" and was thankful that we called to check on him.
Extremely sore shoulder. Affects ability to perform daily tasks even now after one week after the vaccination. Administrator indicated the needle was hard to get through "thick skin." Can barely lift arm, cross it over body, dress self, use restroom, etc. Not recovered to date.
SHE RECEIVED HER COVID-19 VACCINE ON MONDAY 8/2 AND FELT FINE. TUESDAY, SHE STARTED HAVING INCREASING PAIN UNDER HER LEFT ARM THAT EVENTUALLY SPREAD TO HER UPPER BREAST. IT WAS SWOLLEN AND PAINFUL TO THE POINT THAT SHE SAW A VIRTUAL MD, WHO TOLD HER TO SEE THE PHARMACY SHE WENT TO . I TOLD HER SHE NEEDED TO SEE AN MD IN PERSON AND I WOULD FILE THE APPROPRIATE REPORTS. I GAVE HER THE COUNTERMEASURES INJURY COMPENSATION PROGRAM NUMBER AND WEBSITE TO VISIT. I SPOKE TO HER ON FRIDAY 8/6 AND SHE HAD SEEN AN MD WHO GAVE HER IBUPROFEN AND APAP FOR THE PAIN, BUT DIDN'T WANT HER TO DO ANYTHING TO DECREASE EFFECTIVENESSOF THE VACCINE. THEY SAID IT WAS COVID ARM AND THAT IT WOULD GO AWAY IN A COUPLE OF WEEKS. SHE SAID IT WAS STILL PAINFUL AND SWOLLEN AT THIS POINT.
This spontaneous report as received from a Registered Nurse refers to a 13 year old male patient. On 30-OCT-2014 the patient was vaccinated with second dose of VAQTA (lot# reported as 010AE, expiration date 24-OCT-2014) 0.5 ml, intramuscularly which was expired. The first dose of VAQTA was administered in August 2013. No adverse effects noted to patient. The patient did not seek medical attention. Additional information has been requested.
The report I am making today is about shingles which were first observed on 11/6/2023. I didn't have any other symptoms after the vaccination.
Beginning 5/20/21, I have had numbness & tingling in feet and hands.
within 12 hours, severe body aches, chills as well as sore arm, joint pain,  within 32 hours, slight swelling above lip and on lip, within 42 hours swelling of face with tenderness, redness and swelling of lymph nodes
Fever; body ache; Chills; Headache; This is a spontaneous report from a contactable Nurse (patient). A 45-year-old male patient receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number: EK5730), via an unspecified route of administration on 21Dec2020 at single dose to prevent COVID. Medical history included ongoing cholesterol abnormal. Concomitant medication included metformin and Cholesterol Medicine. The patient experienced Fever, body ache, Chills, Headache on 22Dec2020. Nurse stated, he have some question regarding the side effects of COVID Vaccine. He received the COVID Vaccine on 21Dec2020 (Monday), he was a nurse and knew it was normal to get fever in some cases but he has had a fever, body ache, the chills, the headaches. He did take Ibuprofen, Tylenol to cut the fever around the clock for the last three days. Nurse further stated, "he wanted to know how long he was going to expect the fever, the chills, the body ache. It was a bit too long and started to worry him. When probed for the causality, Nurse stated, "These are related to vaccine because he tested negative to COVID-19 on 21Dec2020 (Monday) and these symptoms started the next day after the vaccine on 22Dec2020." Therapeutic measures were taken as a result of fever. The outcome of the events was unknown. The causality assessment for events Fever, body ache, Chills, Headache was provided as related by Reporter via Method of assessment Global Introspection.
Varicella vaccine break through. Diagnosed in office by Dr with varicella on 4-28-09. Had 7 lesions. No fever. Had VARIVAX x 2.
Information has been received from a health professional concerning an 67 year old female with no pertinent medical history who on 13JAN2004 was vaccinated with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine. On 13JAN2004 the pt developed "swelling, itching and hot around injection site". The pt was told to put ice on the affected area. The outcome is unknown at this time. Unspecified medical attention was sought. There was no product quality complaint. No lab diagnostic studies were performed. The reporter also indicated that three other pts were vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Additional information has been requested.
Pain and soreness in left arm, upper back, and neck as well as nausea day of administration (12:30am). Ongoing on and off nausea since administration. Deep burning sensation on side left side between neck and shoulder. Mild joint pain. Ongoing fatigue (11 days).
I have ulcerative colitis. I had my first loose/bloody stool the day after taking the vaccine after being in remission for around 1 year on Entyvio. Following the day after the vaccine, I continued to have worsening diarrhea, blood in stool, and abdominal cramping. This being a UC flare was supported with negative C. diff,  negative ova and parasite, and elevated fecal calprotectin of 791 ug/g. This forced me to limit my diet, and I consequently lost around 30 lbs. Because these symptoms were occurring despite a normal vedolizumab level and no antibodies, I was forced to start a course of prednisone, which I had not had to do previously for a year.
This spontaneous report as received from an administrator (also mentioned as representative and healthcare worker) refers to a female patient of unknown age. No pertinent medical history and drug reactions/allergies were reported. On 09-JUN-2014, the patient was vaccinated with PNEUMOVAX 23 Lot # J011799, 09-FEB-2015, subcutaneous in the arm. On an unspecified date in June 2014 the patient experienced skin surface infection below the injection site and streaking down her arm. On 11-JUN-2014, the patient sought medical attention by visiting the office. No lab diagnostics studies were performed. The patient was treated with Cephalexin (also reported as ephalexin. The outcome of skin surface infection streaking down her arm was not reported. Relatedness between skin surface infection below the injection site and streaking down her arm and therapy with PNEUMOVAX 23 was not provided. Additional information has been requested.
Few vesicular lesions appeared 4 days after injection left thigh at injection site. 1/2 on peri, 1/2 on right arm and 1/2 on right lower leg. No fever;no itching. Requirements to parent given, Mild varicella vs. infect sites
Provider administered shot while standing, with myself seated, placed the shot too high. Suspect SIRVA. Injection of vaccine was administered on the upper portion of deltoid, very near shoulder. There was a popping feeling in shoulder when needle was placed. By the evening, the upper arm and shoulder was extremely sore, range of motion was limited due to pain. The soreness did not subside, and instead got worse. Range of motion became more limited, occasional numbness in fingers and hands, shooting, tingling hot pain, cannot sleep on left side, difficulty nursing baby, lifting children, even a month out. Dr appt scheduled for 11/21/16.
Upper arm pain (same as injection arm, 4/10) Reduced arm motion (cannot reach past 90 deg angle) Slight, low-grade fever Increased headache Light sensitivity (did not have pre-injection) Eye pain (2/10) Mucus at back of throat
covid vaccine breakthrough case  dose 1 Pfizer  6/2/21  EW0172
Patient came in outpatient walk-in and states she wants to get shingles vaccine after giving patient vaccine CMA noticed patient received in Jan 2015. (Patient has recvd 2-Zosters).
Patient's family called our office on 4-11-08 stating she was c/o nausea and diarrhea on 4-10-08, but feeling some better on 4-11-08.  The nurse advised the family to seek medical attention if symptoms continued or got worse.  On 4-18-08 the patients son-in-law contacted our office.  He informed us patient had seen her physician who was admitting her to the hospital with a concern of renal failure.  6/13/08 Reviewed hospital medical records of 4/18-4/24/2008. FINAL DX: acute cholecystitis w/cholelithiasis w/gangrenous & purulent gallbladder; anemia secondary to blood loss; atrial fibrillation w/rapid ventricular response, resolved; HTN; NIDDM; hypothyroidism. Records reveal patient experienced abdominal pain, nausea, vomiting, diarrhea, dehydration x 7 days prior to admit.  Surgery of lap cholecystectomy.  Developed atrial fib post operatively & had very slow recovery overall.  D/C to home w/PICC line for continued IV antibiotics.
Received shot on Wednesday noticed soreness to upper (L) deltoid & axilla on Thursday & noticed a sore nodule under (L) axilla on Sunday.
Developed pain in her right shoulder and swelling and redness at the injection site. Treated with ABX by her PCP. Still having pain in the right shoulder and now in the right elbow.
This case was reported by a nurse and described the occurrence of rash in a 33 year old male patient who received hepatitis B vaccine recombinant (Engerix B). The patient had no preexisting medical conditions. The patient was not receiving any concurrent medications. On an unspecified date in August 2004, the patient received the first dose of Engerix B. At an unspecified time following the first dose of Engerix B, on an unspecified date in 2004, the patient experienced a rash. The rash resolved on an unspecified date in 2004. On an unspecified date in 2004, the patient received the second dose of Engerix B. At an unspecified date in 2004, the patient experienced a rash. The rash resolved on an unspecified date. On March 3 2005, the patient received the third dose of Engerix B in the left arm (lot AHBVB030AA). On an unspecified date in March 2005, on or before March 8 2005, the patient again experienced a rash. The nurse described the rash as a much more substantial rash on his forehead and left cheek, looks like hives. The patient was seen by a dermatologist. The rash was ongoing at the time of initial reporting, 3/08/2005.
On 01/18/2023 , I started having nasal and chest congestion, post nasal drip and body aches. On 01/19/2023, I had a fever and severe body aches. I reached out to my physician and was prescribed a course of PAXLOVID.
This spontaneous report as received from a registered nurse refers to a 8 years old female patient. The patient was vaccinated intramuscularly with a dose of lot # (672653/1860AA), 0.5 ml GARDASIL on 21-AUG-2012 into her left deltoid. No other co-suspects were reported. No concomitant medications were reported. The patient was 8 years an 2 months old at the time of administration. No adverse effect was reported. Additional information has been requested.
Information has been received from a physician concerning a 42 year old female with multiple sclerosis who on 29-JUL-2008 was vaccinated with a dose of MMR II (661070/0662X). Concomitant therapy included EFFEXOR, "oxybutane" and radiation therapy. Soon after the vaccine, the patient's condition began to rapidly decline. She developed numbness and paralysis from the waist down. The patient sought medical attention by going to the emergency room but was not admitted to the hospital. At the time of reporting the patient was not recovered. The reporter considered worsening of multiple sclerosis to be disabling. Additional information has been requested.
pt recvd vax 21JAN93 3PM; p/noon pt mom called to say pt was very restless during the noc & ran fever all noc; pt recvd APAP; pt has been crying all day; mom states this was not a nl cry, more shrill than usual; pt went to see MD;
On 08/20/2021 I got the first vaccine and on 9/9/2021 I started to feel the my first symptoms.  It started out as twitching and tingling in my feet. It progressed over the next couple of weeks by turning into intense vibrating in the back of my knees and the twitching and vibrations persisted in my feet. The symptoms subsided after a month and a half, until recently. Recently about 11 days ago I started to feel tendon pain in the back of my legs, like intense pain where it feels like you have an injury. The twitching and tingling also came back recently. Also, my muscles are stiff and my circulation feels terrible, my toes go numb very easily when driving, even on short rides. Most recently, as well, my vision in my left eyes has started to go blurry. These symptoms are terrifying and they all started after receiving the vaccinations. I am praying I get better and I am not even religious.